Skip to main content

Closed

EXOZ: eXoZymes, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-362.4%

Financially safe

Stretched

Debt / equity0.76×

Interest coverage0.0×

Current ratio1.32×

eXoZymes, Inc.

EXOZNASDAQ Global Market·USD·Closed

eXoZymes, Inc.

EXOZNASDAQ·USD·Closed

$4.65

+1.09%

$4.65

+$0.05 (1.09%)

52W Range

2thpctl

Volume

0.23×avg

Mkt Cap

43.16MUSD

P/E

-4.0TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.23×avg

Market Cap

43.16MUSD

P/E Ratio

-4.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings